Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TAZAROTENE
- Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
- A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
- Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
- Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars
- Excimer Laser With Topical Agents in Psoriasis Vulgaris
- Efficacy of Tazarotene in Treatment of Verruca Plana
- A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.
- Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
- A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
- Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
- Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19
- Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
- A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
- A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
- Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
- Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring
- Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris
- A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
- A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
- Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris
- Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris
- Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
- A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris
- Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
- Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris
- Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis
- Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis
- A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
- A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
- A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
- A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
- Efficacy & Safety of Clindamycin and Tretinoin in Acne
- Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis
- Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
- A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
- Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis
- Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
- Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris
- Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
- Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
- Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
- Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
- Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
- Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
- Sorafenib-induced Hand- Foot Skin Reaction Treatment
- Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails
- Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
- The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance
- Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris
Clinical trials list
click for details